PET、PET-CT对甲状腺结节的诊断价值

唐怡云; 王辉; 唐怡云; 王辉

doi:10.3760/cma.j.issn.1673-4114.2012.02.004

[1]

Deandreis D, A1 Ghuzlan A, Auperin A, et al. Is(18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?. Thyroid, 2012, 22(2): 165-172. doi: 10.1089/thy.2011.0255

[2]

Traugott AL, Dehdashti F, Trinkaus K, et al. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative ¹⁸F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg, 2010, 34(6): 1247-1253. doi: 10.1007/s00268-010-0398-3

[3]

de Geus-Oei LF, Pieters GF, Bonenkamp JJ, et al. ¹⁸F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med, 2006, 47(5): 770-775.

[4]

Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?. Am J Otolaryngol, 2008, 29 (2): 113-118. doi: 10.1016/j.amjoto.2007.04.006

[5]

Smith RB, Robinson RA, Hoffman HT, et al. Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngol Head Neck Surg, 2008, 138(1): 101-106.

[6]

Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery, 2003, 133 (3): 294-299.

[7]

Vriens D, de Wilt JH, van der Wilt GJ, et al. The role of[(18)F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: Systematic review and meta-analysis of the literature. Cancer, 2011, 117(20): 4582-4594. doi: 10.1002/cncr.26085

[8]

Shie P, Cardarelli R, Sprawls K, et al. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun, 2009, 30(9): 742-748. doi: 10.1097/MNM.0b013e32832ee09d

[9]

Ohba K, Nishizawa S, Matsushita A, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by ¹⁸F-fluorodeoxyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J, 2010, 57(5): 395-401. doi: 10.1507/endocrj.K10E-008

[10]

Nilsson IL, Arnberg F, Zedenius J, et al. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World J Surg, 2011, 35(12): 2691-2697. doi: 10.1007/s00268-011-1291-4

[11]

Wong C, Lin M, Chicco A, et al. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography(PET/CT) in patients with non-thyroidal malignancy. Acta Radiol, 2011, 52(8): 899-904. doi: 10.1258/ar.2011.110078

[12]

Ho TY, Liou MJ, Lin KJ, et al. Prevalence and significance of thyroid uptake detected by (18)F-FDG PET. Endocrine, 2011, 40(2):297-302.

[13]

Bonabi S, Schmidt F, Broglie MA, et al. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact[J/OL]. Eur Arch Otorhinolaryngol, 2012[2012-02-10]. http://www.springerlink.com/content/g330467522203587. [published online ahead of print Feb 2, 2012]

[14]

Boeckmann J, Bartel T, Siegel E, et al. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake[J/OL]?. Otolaryngol Head Neck Surg, 2012[2012-02-10]. http://www.ncbi.nlm.nih.gov/pubmed/22307576. [published online ahead of print Feb 3, 2012].

[15]

Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol, 2009, 7: 63. doi: 10.1186/1477-7819-7-63

[16]

Kang BJ, O JH, Baik JH, et al. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med, 2009, 23(8): 729-737. doi: 10.1007/s12149-009-0299-4

[17]

Mitchell JC, Grant F, Evenson AR, et al. Preoperative evaluation of thyroid nodules with ¹⁸FDG-PET/CT. Surgery, 2005, 138(6): 1166-1174.

[18]

D'Souza MM, Marwaha RK, Sharma R, et al. Prospective evaluation of solitary thyroid nodule on ¹⁸F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl MED, 2010, 24(5): 345-355. doi: 10.1007/s12149-010-0357-y

[19]

Zhai G, Zhang M, Xu H, et al. The role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. J Endocrinol Invest, 2010, 33(3): 151-155.

[20]

Jeong HS, Chung M, Baek CH, et al. Can[¹⁸F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?. Laryngoscope, 2006, 116(12): 2133-2137. doi: 10.1097/01.mlg.0000243043.65560.3f

[21]

Choi JW, Yoon YH, Kim SM, et al. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial ¹⁸F-FDG PET/CT. Ann Surg Oncol, 2011, 18(5): 1306-1311. doi: 10.1245/s10434-010-1469-2

[22]

Yun M, Noh TW, Cho A, et al. Visually discernible[¹⁸F] fluorodeoxyglucose uptake in papillary thyroid microcarcinoma:a potential new risk factor. J Clin Endocrinol Metab, 2010, 95(7): 3182-3188. doi: 10.1210/jc.2009-2091